J&J 4Q Sales Rise Despite Pandemic, but Charges Cut Profits | Business News
A big jump in prescription drug sales boosted fourth-quarter revenue at Johnson & Johnson, despite the coronavirus pandemic cutting into sales of products from contact lenses to surgical equipment and other medical devices used in procedures at hospitals swamped with COVID-19 patients. Profits dove 57% due to higher research spending, plus litigation and other one-time … Read more